Why the memory persists
Decades of household presence build an association that a corporate transaction does not undo. The brands did not change their names or their look — only the company behind them changed.
Global Healthcare Brand Intelligence
Johnson & Johnson: understand the company today — not only the brands you remember
The company that made the products in your bathroom cabinet is not the company that owns them now. Johnson & Johnson today is a prescription-medicine and medical-technology business. Its household brands left in 2023 and belong to Kenvue. Every ownership statement on this page carries the date it was checked.
Structure verified 28 July 2026 Medicine and MedTech separated Ownership-level verification
Quick Corporate Answer
What is Johnson & Johnson today?
Johnson & Johnson is a global healthcare company operating through two segments: Innovative Medicine, its prescription pharmaceutical business, and MedTech, its medical devices and surgical technologies business. Its former Consumer Health division was separated in 2023 and now trades independently as Kenvue, which holds the familiar household brands many people still associate with the Johnson & Johnson name. As of 28 July 2026, Kenvue remains a separate listed company and a proposed acquisition by Kimberly-Clark is pending completion. Johnson & Johnson should not be treated as a single current consumer-product catalogue.
Two segments todayInnovative Medicine and MedTech. Prescription and professional, not retail.
The consumer brands left in 2023Johnson's, Neutrogena, Aveeno and the rest are Kenvue brands now.
A transaction is pendingKimberly-Clark's acquisition of Kenvue has not closed as of 28 July 2026.
No haircare catalogue hereNo current J&J hair or scalp product is verified for our catalogue.
Medically reviewed by Dr. Amit S. Agarkar — MBBS, MD Dermatology, FCPS, DDV · Medical review 28 July 2026 · Corporate information verified 28 July 2026 · Next review July 2027
What you'll learn on this page
- What Johnson & Johnson actually is today, and what it no longer does
- Where the familiar consumer brands went, and who owns each one now
- The exact status of the pending Kimberly-Clark transaction, with dates
- How to check any healthcare brand's current owner yourself
- Why dermatology relevance is not the same as hair-loss relevance
- Why a MedTech system is not a product you can buy
- Which scalp presentations need a dermatologist rather than a brand page
- Why we show no products here rather than filling the gap with someone else's brands
Current Structure
Two businesses, both professional
Johnson & Johnson's own reporting describes a company organised around two segments. Neither of them sells to consumers directly, which is the single most useful thing to know before searching for a product under this name. Verified 28 July 2026
Segment A
Innovative Medicine
Prescription pharmaceuticals, formerly Janssen. Prescription products for diagnosed conditions, reaching patients through clinicians rather than through a shop.
Therapeutic areas:
Oncology · Immunology · Neuroscience · Cardiovascular & Metabolism · Pulmonary Hypertension · Infectious Diseases
Segment B
MedTech
Medical devices and surgical technologies. Supplied to hospitals, surgeons and eye-care professionals — procured institutionally, not purchased by consumers.
Areas:
Surgery · Orthopaedics · Cardiovascular · Vision
Notice what is absent from that list: shampoo, baby care, plasters, mouthwash, painkillers. None of those are Johnson & Johnson businesses any more, which is why a search for a familiar product under this name almost always leads somewhere else.
The Separation
The consumer brands moved — but the familiarity remained
People still search for shampoo, baby wash and plasters under the Johnson & Johnson name because they grew up with that association. It was accurate for a very long time. It stopped being accurate in 2023. Verified 28 July 2026
Why old content still says otherwise
Packaging, retailer listings and articles produced before 2023 remain in circulation and are rarely updated. Old branding tells you when the content was made, not who owns the brand today.
Why this page separates them
Attributing a product to the wrong company sends you to the wrong place to check a formulation, a claim or a safety update. That is the practical cost of a nice-sounding simplification.
A historical association is not a current ownership statement — and only one of them is useful when you are checking a label.
Corporate Timeline
What happened, when, and what has not happened yet
Eight events, each with its status shown plainly. The last one has not occurred, and this page is careful to say so.
May 2023
Kenvue IPO
Johnson & Johnson begins separating its Consumer Health business.
Source type: J&J / Kenvue corporateCompleted
August 2023
Split-off completed
J&J distributes its remaining Kenvue shares; separation complete.
Source type: J&J / Kenvue corporateCompleted
2024
Janssen becomes Innovative Medicine
Pharmaceutical business consolidated under the Innovative Medicine name.
Source type: J&J corporateCompleted
2 November 2025
Merger Agreement signed
Kimberly-Clark agrees to acquire Kenvue for stock and cash.
Source type: SEC filingCompleted
29 January 2026
Shareholders approve
Both Kimberly-Clark and Kenvue shareholders approve the transaction.
Source type: Investor releaseCompleted
4 February 2026
US antitrust waiting period expires
Hart-Scott-Rodino waiting period expires.
Source type: SEC filingCompleted
15 April 2026
Post-closing structure announced
Kimberly-Clark names leadership effective on completion; deal on track for H2 2026.
Source type: Investor releaseCompleted
Second half of 2026
Expected completion
Subject to foreign regulatory approvals and other closing conditions.
Source type: SEC filingPending
Sources: Johnson & Johnson corporate reporting; Kimberly-Clark and Kenvue investor releases; Kimberly-Clark SEC filings. Status current as of 28 July 2026. [RE-VERIFY BEFORE EACH PUBLICATION — a pending transaction can close, be modified or be terminated at any time]
Legacy Brand Ownership
Looking for a familiar Johnson & Johnson consumer brand?
Eight brands, each checked individually rather than swept into one statement. All eight moved with the Consumer Health separation — but ownership is verified brand by brand because it can differ by market, licence and transaction. Verified 28 July 2026
Former J&J Consumer Health
Johnson's
- Category
- Baby and gentle skincare
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Former J&J Consumer Health
Neutrogena
- Category
- Skincare and haircare
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Former J&J Consumer Health
Aveeno
- Category
- Sensitive skincare and body care
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Former J&J Consumer Health
Clean & Clear
- Category
- Acne-prone skincare
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Former J&J Consumer Health
Listerine
- Category
- Oral care
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Former J&J Consumer Health
Band-Aid
- Category
- First aid
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Former J&J Consumer Health
Tylenol
- Category
- Pain relief
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Former J&J Consumer Health
Nicorette
- Category
- Smoking cessation
- Former relationship
- Part of Johnson & Johnson Consumer Health until 2023
- Current owner
- Kenvue
- India-facing marketer
- Not yet verified
- Ownership verified
- 28 July 2026
Note the "not yet verified" on every India-facing marketer. The global brand owner and the entity that markets a product in a given country are different things, and the second is what appears on your pack. We have not confirmed those individually, so we do not state them — an honest gap is more useful than a confident guess.
Data Transparency
What we deliberately did not verify
Four things this page could have asserted and does not, because no official source confirmed them at the time of writing.
Regaine / Rogaine
Ownership and India-facing marketer could not be confirmed from an official source at the time of writing. Historically a Johnson & Johnson consumer brand in some markets, but that does not establish current ownership.
India-facing marketer for each legacy brand
Entity names differ by market and were not confirmed individually.
Any J&J hair or scalp product in the HairsnCares catalogue
None verified — the catalogue shows an honest empty state.
Product-level prices, stock and availability
Catalogue data, not corporate data.
The Regaine and Rogaine entry is the one worth dwelling on. It is a hair-loss brand, which makes it the most tempting thing on this page to claim a connection to — and precisely for that reason it gets a "not verified" rather than an inference from its history.
Brand-Ownership Checker · Interactive
Check who owns a brand — and when we checked
Select a brand and a market. The answer comes back with its current owner, its former relationship, its verification date and an honest marker where something could not be confirmed.
Brand-ownership checker
Runs entirely in your browser. It reports what we verified and flags what we did not — it never infers ownership from packaging design or from a brand's history.
Ownership status
This checker reports corporate ownership only. It does not confirm that a product is available, suitable or safe for you, and it is not a substitute for the information printed on the pack you are holding. Ownership can change — always note the verification date.
Dermatology Relevance
Where this company genuinely intersects with skin — and where it does not
There is a real intersection, and overstating it would be the easiest mistake on this page to make. Immunology research touches inflammatory skin disease. That is a long way from a hair-loss offering.
Where the relevance is real
- Immunology research into immune-mediated disease
- Prescription medicines for defined inflammatory conditions
- Surgical and wound-care technology used in procedures
- Clinical research and professional education
Where it stops
- An approved medicine treats its approved indication, not adjacent ones
- Dermatology expertise is not hair-growth expertise
- Research capability says nothing about individual suitability
- Corporate scale is not clinical evidence for your case
What that means for you
- Prescription products require a diagnosed indication
- Approval and availability differ by country
- No medicine here is presented as a scalp treatment
- Your diagnosis decides the pathway, not the company name
A company's dermatology expertise does not make every company product appropriate for scalp disease or hair loss.
No medicine is named on this page for an unapproved use. Repurposing a prescription immunology medicine by implication — mentioning it near a discussion of scalp inflammation and letting the reader draw the line — is a real failure mode for pages like this one. Nothing here does it.
Relevance Map
Your concern, and where it actually leads
Nine common reasons people arrive at a page like this, and where each one should send you. In most cases the honest answer is somewhere other than here.
Concern, Relevance And Correct Pathway
| Hair or scalp concern | Genuine relevance | Correct pathway |
|---|---|---|
| Pattern hair loss | No verified product from this company | Hair-loss assessment |
| Patchy autoimmune hair loss | Specialist dermatology context only | Dermatologist review |
| Scarring alopecia | Urgent specialist assessment | Medical consultation — time-sensitive |
| Inflamed or painful scalp | Diagnosis required first | Scalp evaluation |
| Hair-transplant surgery | Professional products may have procedural context | Surgeon-led pathway |
| Wound care after a procedure | Procedure-specific medical context | Your clinician's instructions |
| Consumer shampoo | Usually a former Consumer Health brand | Check the current owner |
| Sensitive-skin product | Verify current owner and current label | Correct brand catalogue |
| Baby shampoo | Not a current J&J product | Legacy-brand ownership check |
This map does not diagnose. Presentations overlap and more than one can be present at once. Use it to work out which conversation to start — and note that scarring alopecia and an inflamed painful scalp both belong in the urgent column, whatever else is going on.
Verified Product Discovery
Johnson & Johnson products on HairsnCares
A product appears here only if its current ownership, India-facing availability, identity, classification, prescription status and consumer-purchase eligibility have all been verified. Legacy consumer brands are never counted in this catalogue.
Filter verified products
0 verified Johnson & Johnson products match your filters
No directly verified Johnson & Johnson haircare listings are currently connected
Johnson & Johnson's current healthcare portfolio should not be confused with consumer brands historically associated with the company. HairsnCares will display a product here only after verifying its current owner, India-facing marketer, classification and hair or scalp relevance.
Filling this space with Kenvue brands would be the easy option and the dishonest one. The empty state is the accurate answer.
Explore dermatology brands · Start hair-loss assessment · Ask Dr Amit
Category Intelligence
Medicine, MedTech, consumer health and cosmetics are four different things
Each does something real. None substitutes for another, and the differences in who buys them and what safeguards apply are the whole point.
Category, Purpose, User And Safeguard
| Category | Typical purpose | Buyer or user | Key safeguard |
|---|---|---|---|
| Innovative Medicine | Treat diagnosed diseases | Eligible patients under clinical guidance | Prescription and approved indication |
| MedTech | Support clinical procedures or diagnosis | Healthcare professionals and institutions | Professional-use requirements |
| Consumer health | Everyday self-care | Consumers | Current brand ownership and label |
| Cosmetic haircare | Cleansing and appearance | Consumers | Does not equal medical treatment |
| Dermatology prescription | Treat a defined skin condition | Diagnosed patients | Specialist selection and monitoring |
Read the fourth column. It is the one that explains why you cannot buy a surgical system, why a shampoo is not a treatment, and why a prescription medicine needs a diagnosis before it needs a supplier.
Professional Use
Visible online does not mean available to you
MedTech systems are documented publicly because clinicians and procurement teams need that documentation. Specification sheets are not consumer marketing, and they should not be read as such.
Who these are for
- Hospitals and clinics through institutional procurement
- Surgeons and proceduralists trained on the system
- Eye-care professionals for vision products
- Not consumers, at any price
Common misreadings
- Treating a device specification as a consumer benefit claim
- Assuming online visibility implies availability
- Reading a surgical product as an at-home tool
- Inferring a platform endorsement from a manufacturer's name
On hair restoration specifically
- Clinics use products from many manufacturers
- Surgeon choice depends on procedure, patient and availability
- A manufacturer's presence is not a HairsnCares endorsement
- Ask your surgeon what they use and why
Status badges used across this page
Current business Former Consumer Health Transaction pending Prescription medicine Professional use only Not yet verified Medical review recommended
Each carries an icon and a text label as well as a colour, so status never depends on colour alone.
Not available for direct purchase
Where a product carries this status, no price, stock figure or purchase route appears anywhere on this page — including in any future catalogue entry. The data structure enforces it rather than relying on editorial care.
Hair-Loss Pathway Finder · Interactive
Find the right next step — brand-neutral
Twelve questions answered in your browser. Deliberately brand-neutral: it will send you to a different company's page, or to an appointment, whenever that is the right answer.
Hair-loss pathway finder
Answer what you can. Red-flag answers override everything else, because some presentations need examining before any product or brand question matters.
Suggested pathway
This tool provides educational navigation only. It does not diagnose hair loss, prescribe a medicine or confirm product suitability. If you are already under the care of a clinician, follow their advice over anything suggested here.
Safety
When to stop reading and get assessed
A corporate brand page is a poor place to be if any of the following applies. Listed plainly, without alarm — several are simply time-sensitive.
Seek prompt assessment
Red flags
- Sudden patchy hair loss
- Visible scarring or shiny smooth areas
- Painful scalp
- Pus or crusting
- Bleeding
- Rapidly progressive loss
- Severe swelling
- Fever alongside scalp symptoms
- Loss of eyebrows or eyelashes
- Hair loss with systemic illness
- A significant reaction to a treatment
- Delayed wound healing after a procedure
Raise before starting anything
Circumstances that change the conversation
- Pregnancy and breastfeeding
- Children and older adults
- Immunosuppressive treatment
- Existing medicines and possible interactions
- Known allergies
- Active infection
- Recent surgery or a healing wound
- Any off-label or unapproved use being considered
- Products bought outside a licensed supply chain
Scarring alopecia is the one to act on quickly. Where inflammation is destroying follicles, hair lost during a delay does not return. Shiny smooth patches, visible scarring, persistent pain or crusting all warrant an appointment rather than more reading.
Verification
Checking a pack — and checking who actually owns it
Two separate questions, and most guidance only covers the first. With a brand that has changed hands, the second matters just as much.
Verify the identity
- Confirm the exact product name and variant
- Check the marketer named on the pack
- Review the manufacturer
- Confirm the product classification
Verify the ownership
- Check the current owner's own corporate site
- Note the date you checked it
- Treat old packaging as historical, not evidential
- Remember the marketer can differ from the global owner
Verify the pack
- Check batch number and expiry
- Inspect packaging integrity
- Compare the current label with official data
- Retain the carton and invoice
- Be cautious of unusually low prices
Historical Johnson & Johnson branding on old content or packaging does not by itself confirm current ownership or current product status. Stock in circulation can predate a separation by years, and a printed name is a record of when something was made.
Evidence & Sources
Where every corporate statement here comes from
Corporate facts on this page come from company reporting, investor communications and regulatory filings — not from news summaries or encyclopaedia entries.
Source Type, What It Established And When Checked
| Source type | What it established | Checked |
|---|---|---|
| Company annual reporting | Current two-segment structure and therapeutic areas | 28 July 2026 |
| Quarterly earnings materials | Continuation of that structure into 2026 | 28 July 2026 |
| Regulatory filings | Merger agreement terms, antitrust milestone, expected completion window | 28 July 2026 |
| Investor communications | Shareholder approval and post-closing structure announcement | 28 July 2026 |
| Corporate brand listings | Which consumer brands sit with the current owner | 28 July 2026 |
| Not used as evidence | Marketplace listings, old packaging, encyclopaedia entries, social posts | — |
Standing note: a pending transaction can close, be modified or be terminated at any time. Every ownership statement here is qualified by its verification date for exactly that reason. [RE-VERIFY BEFORE EACH PUBLICATION AND AT EVERY REVIEW CYCLE]
Medically Reviewed Content
Dermatologist-reviewed corporate guide
"A familiar corporate name should never replace verification of the current product owner, the exact indication and individual medical suitability. Patients arrive convinced a product is safe because they recognise the company that made it when they were children. That recognition is memory, not evidence."
Healthcare & Hair Science Journal
Read further
The biology underneath the hair-loss questions this page keeps redirecting to.
The hair growth cycle
Why shedding often follows a trigger by months, and why nothing visible happens quickly.
Read the growth cycle →
Scalp biology
Barrier, sebum and microbiome — the ground on which inflammation and scarring actually happen.
Read scalp biology →
The hair follicle
What is lost when a scarring condition destroys one, and why that loss is permanent.
Understand the follicle →
Terminology
The vocabulary this page uses
Fourteen terms for reading corporate ownership and healthcare categories precisely.
- Split-off
- A separation in which a parent distributes a subsidiary's shares to its own shareholders, leaving two independent companies. How the Kenvue separation completed in August 2023.
- Innovative Medicine
- Johnson & Johnson's prescription pharmaceutical segment, previously named Janssen.
- MedTech
- Johnson & Johnson's medical devices and surgical technologies segment, supplying professional clinical settings.
- Consumer Health
- The former Johnson & Johnson business comprising household health and personal-care brands, separated in 2023 to form Kenvue.
- Kenvue
- The independent consumer-health company created from Johnson & Johnson's former Consumer Health business, listed as KVUE.
- Pending transaction
- An agreed acquisition that has not completed. Ownership does not change until closing, whatever has been announced.
- Merger agreement
- The contract setting out an acquisition's terms. Signing it does not transfer ownership; completion does.
- Marketer
- The legal entity that markets a product in a given country. It can differ from the global brand owner, and it is what appears on the pack.
- Professional-use product
- A product intended for use by healthcare professionals in a clinical setting, not for direct consumer purchase.
- Prescription medicine
- A medicine supplied against a valid prescription for a diagnosed indication, with prescribing information attached.
- Approved indication
- The condition a regulator has authorised a medicine to treat. Relevance to a related field does not extend that authorisation.
- Immunology
- The therapeutic area concerned with immune-mediated disease, including some inflammatory skin conditions. Not synonymous with hair-loss treatment.
- Scarring alopecia
- A group of conditions in which inflammation destroys follicles permanently. Time-sensitive: delay costs hair that cannot be recovered.
- Ownership verification date
- The date on which a corporate ownership statement was checked. Without it, an ownership claim cannot be relied upon.
FAQs
Johnson & Johnson — thirty questions answered
Every ownership answer is date-qualified, and none claims the pending transaction has completed.
A global healthcare company operating through two segments: Innovative Medicine, its prescription pharmaceutical business, and MedTech, its medical devices and surgical technologies business. It is no longer a consumer-products company, and its own reporting describes it in exactly those terms.
No. The Consumer Health business was separated in 2023 and now trades independently as Kenvue. Johnson & Johnson today is focused on prescription medicines and medical technology.
It became Kenvue. The separation ran through an initial public offering in May 2023 and completed as a split-off in August 2023, when Johnson & Johnson distributed its remaining shares.
The consumer-health company created out of Johnson & Johnson's former Consumer Health business. It holds the familiar household brands people still associate with Johnson & Johnson, and it trades on the New York Stock Exchange under KVUE.
No. The separation completed in August 2023, and the two are now distinct companies with no ownership relationship. Familiarity with the old association is not the same as a current one.
Not as of 28 July 2026. Kimberly-Clark and Kenvue signed a merger agreement in November 2025 and both sets of shareholders approved it in January 2026, but completion remains subject to regulatory approvals and is expected in the second half of 2026. Until it closes, Kenvue remains a separate company.
No — they are separate public companies. Kenvue was created from Johnson & Johnson's former Consumer Health business, which makes them historically related and currently independent of one another.
No. The Johnson's brand went with the Consumer Health separation and now sits with Kenvue. The shared name is a legacy of the company's history rather than a marker of current ownership.
No. Neutrogena is a Kenvue brand following the 2023 separation, and it is where any current Neutrogena product information should be checked.
No. Aveeno moved with the Consumer Health business and is now a Kenvue brand.
No. It went with the Consumer Health separation and now sits with Kenvue, like the other former consumer brands.
No. Listerine is part of the Kenvue portfolio following the separation.
Not as a current business. The haircare and personal-care brands people associate with the name went to Kenvue in 2023. Searching for Johnson & Johnson shampoo will generally lead to a product that is now marketed by a different company.
No hair-loss medicine from this company is listed in the HairsnCares catalogue, and none is claimed here. Its Innovative Medicine portfolio addresses diagnosed diseases across several therapeutic areas, which is a different thing from a hair-loss treatment.
Current ownership could not be confirmed from an official source at the time of writing, so nothing is asserted here. It has historically been a consumer brand in some markets, and history does not establish present ownership — check the current pack and marketer.
The prescription pharmaceutical segment, previously known as Janssen. It works across therapeutic areas including oncology, immunology, neuroscience, cardiovascular and metabolism, pulmonary hypertension and infectious diseases.
The medical devices and technologies segment, covering surgery, orthopaedics, cardiovascular and vision. These products are supplied to hospitals, surgeons and eye-care professionals rather than sold directly to consumers.
Its immunology work is relevant to inflammatory disease, which touches dermatology. That relevance operates through prescription medicines for diagnosed conditions and should not be read as a general scalp or hair offering.
Nothing on this page claims so. A company having dermatology expertise does not make its products appropriate for scalp disease or hair loss, and a prescription medicine approved for one condition is not repurposed by a website's implication.
MedTech products are designed for professional clinical settings and procured by hospitals and clinics. Visibility of a device online does not make it suitable or available for direct purchase.
Not currently. No product from this company has been verified as both currently owned and relevant to hair or scalp care for our catalogue, so this page shows a transparent empty state rather than filling it with former consumer brands.
Packaging, listings and articles produced before the 2023 separation remain in circulation, and marketplaces are slow to update. Old branding reflects when the content was made, not who owns the brand now.
Check the current owner's corporate site and the marketer named on the pack you are actually holding, and note the date you checked. Ownership changes with transactions, so a verification without a date attached is of limited use.
A change of corporate owner is not in itself a safety event. Product safety depends on the current formulation, the label and its suitability for you — which is what to read, rather than the company name on the front.
Not automatically, and not necessarily at the moment of transfer. Formulations can change at any point for unrelated reasons, which is why the current label always takes precedence over any remembered version of a product.
No. HairsnCares is an independent platform with no partnership, sponsorship or commercial relationship with Johnson & Johnson, Kenvue or Kimberly-Clark. This page is editorial.
Prescription medicines and MedTech systems reach patients through clinicians, hospitals and pharmacies rather than through a consumer brand page. Availability differs by market and by product, and none is listed in our catalogue at present.
Under their current owner rather than under this page. Both are Kenvue brands, and any current formulation, claim or availability information should be checked there.
Sudden or patchy loss, a painful scalp, pus, crusting, bleeding, visible scarring, rapid progression or loss of eyebrows and eyelashes all warrant prompt assessment — as does hair loss alongside systemic illness. Scarring conditions in particular are time-sensitive.
Every corporate statement on this page carries the date it was checked, and the page is scheduled for review at least annually — sooner when a transaction is pending, as one is now.
No matching question yetTry a different word, or clear the filter to see all 30 answers.
Your Next Step
Verify the company. Verify the product. Then choose the right healthcare pathway.
Recognising a name is not the same as knowing who owns it, what it does now, or whether any of it applies to you. If you arrived here looking for a hair or scalp answer, the useful next step is almost certainly an assessment rather than a brand.
Explore Johnson & Johnson today · Check brand ownership · Browse former consumer brands
Sources used on this page
Corporate structure, the separation and the status of the pending transaction come from company reporting, investor communications and regulatory filings. Medical framing comes from recognised dermatology bodies. Marketplace listings, old packaging and encyclopaedia entries were not used as evidence of ownership.
- Johnson & Johnson — corporate site and investor reporting (opens in a new tab)
- Kenvue — corporate site and brand portfolio (opens in a new tab)
- Kenvue investor relations — transaction communications (opens in a new tab)
- Kimberly-Clark investor relations — transaction status and post-closing structure (opens in a new tab)
- SEC EDGAR — merger agreement terms, antitrust milestone and expected completion window (opens in a new tab)
- American Academy of Dermatology — hair loss overview (opens in a new tab)
- Central Drugs Standard Control Organization — Indian regulatory authority (opens in a new tab)
External links open in a new tab and lead to independent organisations whose content HairsnCares does not control. No link implies endorsement, partnership or affiliation. [CORPORATE STRUCTURE AND TRANSACTION STATUS LAST VERIFIED 28 JULY 2026 — RE-VERIFY BEFORE EACH PUBLICATION]
Corporate Information Disclaimer: Corporate structure and brand ownership stated on this page were verified on 28 July 2026. As of that date, Kenvue remains a separate listed company and the proposed acquisition by Kimberly-Clark is pending completion, expected in the second half of 2026 and subject to regulatory approvals and other closing conditions. A pending transaction may complete, be modified or be terminated. Ownership may also vary by brand, jurisdiction and licensing arrangement. Verify current official information before relying on any statement here.
Medical Disclaimer: This page provides general educational information about a healthcare company and does not diagnose, prescribe or recommend treatment. Prescription medicines require a diagnosed indication and product-specific prescribing guidance. MedTech products are designed for professional clinical settings and are not available for direct consumer purchase. A company's dermatology research does not make its products appropriate for scalp disease or hair loss, and no medicine is presented here for an unapproved use. Sudden or patchy hair loss, a painful scalp, pus, crusting, bleeding, visible scarring, rapid progression or loss of eyebrows and eyelashes all warrant prompt medical assessment; scarring conditions in particular are time-sensitive.
Trademark and Independence Disclaimer: HairsnCares is an independent dermatologist-led haircare discovery and ecommerce platform. Johnson & Johnson, Kenvue, Johnson's, Neutrogena, Aveeno and all associated trademarks belong to their respective owners. Corporate ownership, product availability, formulation, indication and India-facing marketing arrangements may change. Verify current official information before purchase or use. HairsnCares is not affiliated with, sponsored by or endorsed by Johnson & Johnson, Kenvue or Kimberly-Clark, is not a parent, partner or subsidiary of any of them, and reproduces no corporate logo or wordmark on this page.